(Q39955122)

15 September 2017

1 reference

title

The mechanisms of action of L-dopa in Parkinson's disease (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

13 February 2023

1 reference

O. Hornykiewicz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4620977

13 February 2023

language of work or name

English

0 references

publication date

1 October 1974

1 reference

full work available at URL

15 September 2017

https://api.elsevier.com/content/article/PII:0024320574903063?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

https://api.elsevier.com/content/article/PII:0024320574903063?httpAccept=text/plain

13 February 2023

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

13 February 2023

1 reference

15 September 2017

volume

15

1 reference

15 September 2017

issue

7

1 reference

15 September 2017

page(s)

1249-1259

1 reference

On the presence of 3-hydroxytyramine in brain

15 September 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

13 February 2023

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

l-DOPA treatment in Parkinson's disease: Effect on dopamine and related substances in discrete brain regions

13 February 2023

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

13 February 2023

7

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

13 February 2023

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

13 February 2023

Pharmacological Reviews

9

18

925

Hornykiewicz

1966

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism

13 February 2023

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Growth of Pulmonary Alveolar Macrophages in vitro

13 February 2023

11

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

A quantitative study on the nigro-neostriatal dopamine neuron system in the rat.

13 February 2023

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase

13 February 2023

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice

13 February 2023

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

L-Dopa-Induced Release of Cerebral Monoamines

13 February 2023

16

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Distribution and metabolism of l-3-O-methyldopa in rats

13 February 2023

19

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

3-O-Methyldopa, a New Precursor of Dopamine

13 February 2023

20

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Parkinsonism treated with 3-O-methyldopa

13 February 2023

22

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

l-DOPA induced effects on motor activity in mice after inhibition of dopamine-?-hydroxylase

13 February 2023

23

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

The effect of L-DOPA on brain catecholamines and motility in rats

13 February 2023

24

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

PHARMACOLOGY OF TETRAHYDROPAPAVEROLINE AND ITS FORMATION FROM DOPAMINE

13 February 2023

27

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Tetrahydroisoquinoline alkaloids: uptake, storage, and secretion by the adrenal medulla and by adrenergic nerves

13 February 2023

31

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

On the mode of action of l-dopa in Parkinson's disease

13 February 2023

32

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Dopamine-derived tetrahydroisoquinoline alkaloids—Inhibitors of neuroamine metabolism

13 February 2023

33

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Evidence for the methylation of apomorphine by catechol-O-methyl-transferase in vivo and in vitro

13 February 2023

34

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

A model for the quantitative study of central dopaminergic and serotoninergic activity

13 February 2023

35

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

13 February 2023

36

13

227

Goldberg

1971

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Modification of Parkinsonism--chronic treatment with L-dopa

13 February 2023

39

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Drug Therapy of Parkinsonism

13 February 2023

41

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

L-dopa treatment failure: explanation and correction

13 February 2023

43

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

Decrease in liver aromatic L-amino-acid decarboxylase produced by chronic administration of L-dopa

13 February 2023

44

1 reference

https://api.crossref.org/works/10.1016/0024-3205(74)90306-3

13 February 2023

Identifiers

1 reference

15 September 2017

1 reference